DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Technical Information for the Gamma Rhythm® Chair Equipped with Gamma Wave Induction Technology Released
Ekubo Corporation (Headquarters: Atsugi City, Kanagawa Prefecture; President: Yoshihiro Shimizu) is releasing technical information on the Gamma Rhythm® Chair (Registered Trademark No. 6016327), which incorporates the company's patented “Gamma Wave Induction Device” (Patent No. 6994652).
In recent years, research interest in “gamma waves” and “40Hz stimulation” has been growing both domestically and internationally. This technical disclosure responds to this expanding societal interest. By introducing the background and structure of the technology we have pioneered and implemented, we aim to promote understanding and information sharing within the field of gamma wave research.
This Ultra-Sensitive Sensor Runs on Lemons and Gold, Not Enzymes
The researchers developed a highly sensitive and eco-friendly uric acid sensor using carbon quantum dots (CQDs) synthesized from lemon juice and integrated it into a gold-based SPR platform.
The sensor detects uric acid at ultra-low concentrations (0.002 μM), outperforming traditional methods in speed, sensitivity, and sustainability. Their findings were published in Scientific Reports.
MIT Researchers Build AI Device That Turns Old Photographs Into Custom Scents
The Anemoia Device is a scent-memory machine that uses generative AI to distill analogue photographs into bespoke fragrances. Each image becomes a singular olfactory composition, a multisensory artifact designed to evoke anemoia –– nostalgia for a moment you never lived.
Swiss wearable glucose-monitoring technology startup Liom closes €13.9 million round
Schwyz-based Liom, an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable, announced a €13.9 million (CHF 13 million) extension of its Series A financing round.
The round was led by previous lead investors, with new participation from Red Bull Ventures, Marc Maurer (former co-CEO of On Running), Melih Odemis (former co-founder and CTO of Yemeksepeti), Alejo Costa Ribalta, partner of venture capital firm CRB Health Tech and former senior executive of Philips and GE Healthcare – bringing its total Series A to €40.8 million (CHF 38 million) and its total funding to date to €67.6 million (CHF 63 million).
Startup develops new nanosensors to track chemical reactions in ‘the age of enzymes’
The website video shows a carbon nanotube – a lattice structure measured in billionths of a meter – floating in a solution and glowing red when hit by laser light.
A long strand of a protein substrate, its atoms pictured in green, black and gray, winds around the tube. Floating in from the top is a swirling yellow, purple and magenta ribbon diagram of a protease, a type of enzyme that breaks down proteins. The enzyme quickly snips the protein. There’s a chemical reaction. Suddenly new products are floating around.
And, the fluorescing nanotube goes dark.
Track those light quenches with special readers, and you can measure enzyme activity. And you can do it 62% quicker and with half the steps of existing assays, or lab tests to measure various properties of materials.
That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab of Nigel Reuel, the Stanley Chair in Interdisciplinary Engineering at Iowa State University and co-founder and chairman of the company.
Establishment of a Selection Method for Olfactory Receptors Responding to Odors Present as Gases in the Environment: Evaluation Using Cigarette Smoke Room Air as Target Odor
Estée Co., Ltd. has successfully established a method for selecting olfactory receptors that respond to odors present in the environment as gases. This achievement was made through collaborative research with Associate Professor Yosuke Fukutani of the Department of Life Science and Engineering, Graduate School of Engineering, Tokyo University of Agriculture and Technology. The evaluation system used a model odor derived from smoking room air.
Humans perceive odors when odor molecules bind to approximately 400 types of receptors (odor sensors) located in the olfactory epithelium at the back of the nose. Therefore, identifying which receptors respond to specific malodors is a crucial foundation for developing deodorization technologies that reduce the perception of unpleasant odors.
Demonstration experiment conducted to deliver packages to apartment units using elevator and robot coordination
Mitsubishi Electric Building Solutions Corporation (President: Iwao Oda, Head Office: Chiyoda-ku, Tokyo), Preferred Robotics Inc. (CEO: Tatsu Isobe, Head Office: Chiyoda-ku, Tokyo), and Daiei Sangyo Co., Ltd. (President: Kenji Ichinose, Headquarters: Yahata Nishi-ku, Kitakyushu City, Fukuoka Prefecture) will jointly commence a demonstration experiment on November 27, 2025, and plan to conduct it until January 2026. This experiment involves a system where autonomous transport robots, in coordination with elevators, deliver packages and carts between the lobby and individual rooms within a residential apartment building.
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases with precision interventions[1]. Healthcare systems integrating AI diagnostic tools now match therapies to individual genetic profiles rather than treating broad populations with reactive symptom management[2]. Five companies positioned at this convergence include Avant Technologies, Inc. (OTCQB: AVAI), Beam Therapeutics Inc. (NASDAQ: BEAM), CRISPR Therapeutics (NASDAQ: CRSP), Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), and Schrödinger, Inc. (NASDAQ: SDGR).
Technical Information for the Gamma Rhythm® Chair Equipped with Gamma Wave Induction Technology Released
Ekubo Corporation (Headquarters: Atsugi City, Kanagawa Prefecture; President: Yoshihiro Shimizu) is releasing technical information on the Gamma Rhythm® Chair (Registered Trademark No. 6016327), which incorporates the company's patented “Gamma Wave Induction Device” (Patent No. 6994652).
In recent years, research interest in “gamma waves” and “40Hz stimulation” has been growing both domestically and internationally. This technical disclosure responds to this expanding societal interest. By introducing the background and structure of the technology we have pioneered and implemented, we aim to promote understanding and information sharing within the field of gamma wave research.
Hypoxic Training May Effectively Improve Obesity and Hypercholesterolemia International Study Reports Significant Improvements in Lipid Profile and Body Fat Mass
The latest international research indicates that hypoxic training may be effective in improving hypercholesterolemia associated with obesity and overweight. Compared to exercise under normal oxygen conditions, it significantly improved lipid profiles (including LDL-C, non-HDL-C, and TG) and body fat mass. Furthermore, domestic research has revealed that walking in a hypoxic environment also brings significant improvements in blood glucose control. Hypoxic training is gaining attention as a non-pharmacological intervention for the general public.
Ainos secures seven new patents for AI-powered scent technology
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), whose stock has surged over 40% in the past six months according to InvestingPro data, has secured seven new patents in Europe, Germany, Taiwan, and China for its AI Nose digital olfaction platform, the company announced Tuesday.
The new patents bring Ainos’s total to 123 active patents across the U.S., Europe, Germany, Japan, Taiwan, and China, covering product design, internal structures, system configurations, and operating principles of its scent digitization technology. With a market capitalization of $16.6 million, the company trades at 1.45 times book value.
The AI Nose platform is designed to convert scent into digital data using MEMS sensor arrays and AI algorithms, with applications across multiple industries. The technology aims to provide real-time scent detection for healthcare settings, anomaly detection in semiconductor manufacturing, and sensory capabilities for robotics and automated production lines.
Berkeley alums develop at-home robotic rehabilitation device
With a little serendipity and lots of grit, alumni Todd Roberts (MEng’20 ME) and Owen Kent (B.A.’17 Film) have shown how an idea can turn into a product that makes a difference. The pair first developed Reflex, their robotic rehabilitation device, in a UC Berkeley course on assistive technologies. Now, six years later, they’re launching it through their company, ATDev, which aims to bring high-quality rehabilitation into the home.
The two met when Roberts, an incoming graduate student, responded to Kent’s Craigslist post advertising a room for rent. They became fast friends and, once classes started, realized they were both in Designing for the Human Body, a biomechanics course taught by mechanical engineering professor Grace O’Connell.
Strengthening research and development in collaboration with specialists such as dermatologists to drive growth in the dermatology market in Japan
Shiseido, through collaborative research with the Department of Dermatology and Perinatal and Maternal-Child Center at Tohoku University Hospital (hereinafter referred to as the Department of Dermatology at Tohoku University Hospital), has discovered that infants with high levels of specific proteins in their stratum corneum at two months of age have a higher probability of developing atopic dermatitis or food allergies by age three. This discovery is expected to lead to the establishment of diagnostic methods capable of early prediction of allergy onset risk during infancy. As the number of individuals suffering from atopic dermatitis and food allergies increases, appropriate care based on early prediction can reduce the risk of onset, potentially contributing to improved quality of life for children and their families. This discovery was made through collaboration with the Department of Dermatology at Tohoku University Hospital, following over a decade of research since the initial concept was conceived.
Dr. Maki Ozawa of the Department of Dermatology at Tohoku University Hospital, a co-researcher on this study, received the 2025 Sanofi Outstanding Paper Award in the “General Category” for her paper. Furthermore, these findings were presented at the Japanese Society of Allergy conference held from October 24 to 26, 2025.